{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:57:29Z","timestamp":1773658649778,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.eururo.2005.04.023","type":"journal-article","created":{"date-parts":[[2005,6,24]],"date-time":"2005-06-24T13:41:54Z","timestamp":1119620514000},"page":"478-482","source":"Crossref","is-referenced-by-count":41,"title":["Propiverine versus Tolterodine: Efficacy and Tolerability in Patients with Overactive Bladder"],"prefix":"10.1016","volume":"48","author":[{"given":"Klaus-Peter","family":"J\u00fcnemann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Halaska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Rittstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"M\u00fcrtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frieder","family":"Schnabel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Br\u00fcnjes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Nurkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.eururo.2005.04.023_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1569-9056(02)00043-X","article-title":"Economic and social impact of OAB","volume":"1","author":"Kelleher","year":"2002","journal-title":"Eur Urol Suppl"},{"issue":"11","key":"10.1016\/j.eururo.2005.04.023_bib2","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1517\/13543784.13.11.1493","article-title":"Darifenacin: a novel M3 muscarinic selective receptor antagonist for the treatment of overactive bladder","volume":"13","author":"Chapple","year":"2004","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1016\/j.eururo.2005.04.023_bib3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/PL00007103","article-title":"Oxybutynin and the overactive bladder","volume":"19","author":"Andersson","year":"2001","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2005.04.023_bib4","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s003450100223","article-title":"Efficacy, tolerability and safety profile of propiverine in the treatment of the overactive bladder (non-neurogenic and neurogenic)","volume":"19","author":"Madersbacher","year":"2001","journal-title":"World J Urol"},{"issue":"10","key":"10.1016\/j.eururo.2005.04.023_bib5","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1517\/13543784.13.10.1339","article-title":"The emerging role of solifenacin in the treatment of overactive bladder","volume":"13","author":"Robinson","year":"2004","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1016\/j.eururo.2005.04.023_bib6","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s003450100224","article-title":"Tolterodine: an overview","volume":"19","author":"Wefer","year":"2001","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2005.04.023_bib7","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s003450100225","article-title":"Trospium chloride \u2013 an effective drug in the treatment of overactive bladder and detrusor hyperreflexia","volume":"19","author":"H\u00f6fner","year":"2001","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2005.04.023_bib8","unstructured":"Andersson KE, Appell R, Awad S, Chapple C, Drutz H, Finkbeiner A, et al. Pharmacological treatment of urinary incontinence. In: 2nd International Consultation on Incontinence. July 1\u20133, 2001. 2nd edition 2002."},{"key":"10.1016\/j.eururo.2005.04.023_bib9","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1464-410x.1999.00251.x","article-title":"A placebo-controlled, multicentre study comparing the tolerability and efficacy of propiverine and oxybutynin in patients with urgency and urge incontinence","volume":"84","author":"Madersbacher","year":"1999","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2005.04.023_bib10","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1464-410x.2001.02228.x","article-title":"How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study","volume":"87","author":"Milsom","year":"2001","journal-title":"BJU Int"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228380500268X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228380500268X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T03:54:58Z","timestamp":1548388498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030228380500268X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S030228380500268X"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2005.04.023","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}